Equities

Anpario PLC

Anpario PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)3.78
  • Today's Change0.12 / 3.28%
  • Shares traded--
  • 1 Year change+31.25%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 20:33 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments111416
Total Receivables, Net6.357.256.65
Total Inventory6.359.877.58
Prepaid expenses0.650.530.44
Other current assets, total0.070.020.34
Total current assets243131
Property, plant & equipment, net4.704.914.68
Goodwill, net5.965.965.96
Intangibles, net4.685.425.34
Long term investments------
Note receivable - long term------
Other long term assets0.250.150.11
Total assets404948
LIABILITIES
Accounts payable2.032.702.60
Accrued expenses1.911.172.47
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.030.040.07
Other current liabilities, total0.720.750.11
Total current liabilities4.694.665.24
Total long term debt0.050.020.02
Total debt0.080.050.09
Deferred income tax1.761.722.26
Minority interest------
Other liabilities, total0.050.830.16
Total liabilities6.557.227.68
SHAREHOLDERS EQUITY
Common stock4.625.625.45
Additional paid-in capital151512
Retained earnings (accumulated deficit)142325
Treasury stock - common0(1.19)(1.19)
Unrealized gain (loss)------
Other equity, total(0.12)(0.78)(0.27)
Total equity344140
Total liabilities & shareholders' equity404948
Total common shares outstanding202423
Treasury shares - common primary issue00.440.44
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.